Minimum Effective Volume of Bupivacaine for Serratus Posterior Superior Intercostal Plane Block in Video-Assisted Thoracoscopic Surgery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorBursa City Hospital

About this trial

This study aims to determine the minimum effective volume of bupivacaine required for the serratus posterior superior intercostal plane (SPSIP) block in patients undergoing video-assisted thoracoscopic surgery (VATS). The SPSIP block is an ultrasound-guided regional anesthesia technique used to provide postoperative pain relief after thoracic surgery.

Using a stepwise dose-adjustment method, the volume of local anesthetic will be increased or decreased based on the effectiveness of the block in each patient. The main outcome of the study is to identify the volume that provides effective pain control in 50% of patients. The results may help optimize pain management while minimizing drug exposure.

Eligibility criteria

Qualifiers

Age 18 years or older

Scheduled for elective video-assisted thoracoscopic surgery (VATS)

American Society of Anesthesiologists (ASA) physical status I-III

Planned to receive ultrasound-guided serratus posterior superior intercostal plane block for postoperative analgesia

Disqualifiers

Refusal to participate in the study

Known allergy or contraindication to local anesthetics

Infection at the block injection site

Coagulation disorders or anticoagulant therapy contraindicating regional anesthesia

Trial design

Treatments tested in this trial

  • Ultrasound-Guided Serratus Posterior Superior Intercostal Plane Block

Treatment groups

27 Participants
are divided into 1 treatment group

Sponsors and collaborators

Bursa City Hospital

Lead sponsor

Ulusoy, Emre, M.D.

Collaborator